581 research outputs found
The geometric mean of two matrices from a computational viewpoint
The geometric mean of two matrices is considered and analyzed from a
computational viewpoint. Some useful theoretical properties are derived and an
analysis of the conditioning is performed. Several numerical algorithms based
on different properties and representation of the geometric mean are discussed
and analyzed and it is shown that most of them can be classified in terms of
the rational approximations of the inverse square root functions. A review of
the relevant applications is given
The Pad\'e iterations for the matrix sign function and their reciprocals are optimal
It is proved that among the rational iterations locally converging with order
s>1 to the sign function, the Pad\'e iterations and their reciprocals are the
unique rationals with the lowest sum of the degrees of numerator and
denominator
Solvability and uniqueness criteria for generalized Sylvester-type equations
We provide necessary and sufficient conditions for the generalized
-Sylvester matrix equation, , to have exactly one
solution for any right-hand side E. These conditions are given for arbitrary
coefficient matrices (either square or rectangular) and generalize
existing results for the same equation with square coefficients. We also review
the known results regarding the existence and uniqueness of solution for
generalized Sylvester and -Sylvester equations.Comment: This new version corrects some inaccuracies in corollaries 7 and
PUK4 PHARMACOECONOMIC EVALUATION OF SOLIFENACIN IN THE TREATMENT OF OVERACTIVE BLADDER SYNDROME IN ITALY
PIN49 A PHARMACOECONOMIC EVALUATION OF INFLUENZA VACCINATION IN THE ELDERLY POPULATION IN ITALY
The palindromic cyclic reduction and related algorithms
The cyclic reduction algorithm is specialized to palindromic matrix polynomials and a complete analysis of applicability and convergence is provided. The resulting iteration is then related to other algorithms as the evaluation/interpolation at the roots of unity of a certain Laurent matrix polynomial, the trapezoidal rule for a certain integral and an algorithm based on the finite sections of a tridiagonal block Toeplitz matrix
Palindromic matrix polynomials, matrix functions and integral representations
AbstractWe study the properties of palindromic quadratic matrix polynomials φ(z)=P+Qz+Pz2, i.e., quadratic polynomials where the coefficients P and Q are square matrices, and where the constant and the leading coefficients are equal. We show that, for suitable choices of the matrix coefficients P and Q, it is possible to characterize by means of φ(z) well known matrix functions, namely the matrix square root, the matrix polar factor, the matrix sign and the geometric mean of two matrices. Finally we provide some integral representations of these matrix functions
PRS25 A COST-UTILITY ANALYSIS FOR TIOTROPIUM BROMIDE IN THE LONG TERM TREATMENT OF SPECIFIC SUBGROUPS OF ITALIAN COPD PATIENTS
PDB5 PREVENTION WITH PICOTAMIDE AND ASPIRIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND PERIPHERAL ARTERIAL DISEASE:A PHARMACOECONOMIC EVALUATION
[Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy]
BACKGROUND: Empagliflozin is the most recent molecule in the SGLT-2i class, new antidiabetic drugs that reduce renal glucose absorption by determining the excretion in the urine. The high prevalence of T2D, the chronicity of the condition and the severe economic and social burden caused by the disease, impose the need for a careful health economic assessment on each therapeutic innovation in this area.AIM: The aim of this study was to assess the budget impact of adopting empagliflozin in the diabetic population currently treated with sulfonylureas and potentially eligible for treatment with SGLT-2i.METHODS: The budget impact analysis was conducted from the perspective of the Italian National Health Service over a period of three years, through an analytic model developed in MS Excel. The target population was estimated in about 170,000 patients currently treated with sulfonylureas, based on the growth forecasts of the Italian population, epidemiological estimates and drug-use information available in the literature on diabetes in Italy. In the base case was assumed a replacement rate of sulfonylureas equal to 10%, 20% and 30% respectively at the first, second and third year of analysis. A scenario analysis was considered assuming a constant uptake of 100% since the first year. The following direct healthcare costs were considered: 1) acquisition of antidiabetic drugs as the main therapy and as rescue therapy; 2) self-monitoring of blood glucose; 3) management of severe hypoglycemic events and 4) management of major cardiovascular events. Clinical effectiveness data was based on the published literature and unit costs were derived from current prices and tariffs. Oneway sensitivity analysis was developed to assess the impact of input's uncertainty on the overall result.RESULTS: The base case analysis presented a substantially neutral impact on the budget. The 3-year cumulative impact was -454.337 €, corresponding to a 0.1% saving. This means that the replacement of sulphonylureas with empagliflozin determines an increase in acquisition costs of drugs, which is entirely offset by the reduction in costs of self-monitoring of blood glucose, management of hypoglycemic events and cardiovascular events. The scenario analysis, based on the assumption of a full substitution of sulphonylureas with empagliflozin at the first year, yielded a more enhanced savings. The cumulative impact was -2.269.517 €, corresponding to a 0.6% saving.CONCLUSIONS: The present study shows that the replacement of sulfonylureas (a class of generic products) with empagliflozin, motivated by the advantageous efficacy and safety profile, can take place optimizing healthcare expenditure for the management of DT2.[In Italian
- …